United Kingdom· GB-APID-4399211000001107
Sea-Legs 12.5mg tablets
A meclozine product containing meclozine, registered in United Kingdom by G.R. Lane Health Products Ltd. The same ATC class is registered in 7 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Meclozine is registered in 7 of 19 countries.
Countries holding a registration under ATC R06AE05 (meclozine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Meclozine · ATC R06AE05
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Meclozine
- Manufacturer
- G.R. Lane Health Products Ltd
- Country
- United Kingdom (GB)
- ATC code
- R06AE05
- ATC class
- Meclozine
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5012509080358
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
283 interactions on record for meclozine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Meclozine · interactions on record
283 records
- 9 severe
- 269 moderate
- 5 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Sodium oxybateN01AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Meclozine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMECLIZINERUGBY LABORATORIES
- NetherlandsSuprimal, tabletten 12,5 mgRemark Pharma
- SpainCHICLIDA 25 mg CHICLES MEDICAMENTOSOSFleer Española S.L.
- FinlandPostafenParanova Oy
- BelgiumAgyrax 25 mgMediXal
- FranceAGYRAX, comprimé sécableMEDIXAL
- NorwayAgyrax2care4 ApS
- SwedenPostafen 25 mg TablettCampus Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Agyrax, Postafene
- Denmark · Postafen
- Spain · Chiclida
- Finland · Postafen
- France · Agyrax, Navidoxine
- Greece · Emetostop
- Iceland · Postafen
- Luxembourg · Agyrax, Postafene
- Netherlands · Suprimal
- Norway · Postafen
- Sweden · Postafen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/96211f75-1a17-4e1d-b23c-b92a27ffeca2 GET /v1/drugs/96211f75-1a17-4e1d-b23c-b92a27ffeca2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4399211000001107",
"desc": "Sea-Legs 12.5mg tablets (G.R. Lane Health Products Ltd)",
"form": "Oral tablet",
"vpid": "4427511000001104",
"source": "dmd",
"vtm_id": "776648008",
"strength": "12.5 mg",
"substance": "Meclozine",
"ingredient": "Meclozine hydrochloride",
"supplier_code": "2271601000001103"
}See everything about meclozine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.